Results 311 to 320 of about 94,066 (344)

Clinical development of novel therapeutics for castration‐resistant prostate cancer

Ca-A Cancer Journal for Clinicians, 2012
Matthew D Galsky, Alexander C Small, William K Oh   +2 more
exaly  

Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings

Ca-A Cancer Journal for Clinicians, 2006
exaly  

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

Chemical Reviews, 2016
Timothy C Johnstone, Kogularamanan Suntharalingam, Stephen J Lippard   +2 more
exaly  

Drug Design

2016
openaire   +2 more sources

Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise

Nature Reviews Clinical Oncology, 2019
Daphné Morel, Daniel Jeffery, Sandrine Aspeslagh   +2 more
exaly  

Drug Design

2019
openaire   +1 more source

Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

Nature Reviews Clinical Oncology, 2016
Adi J Klil-Drori, Laurent Azoulay, Michael N Pollak   +2 more
exaly  

Drug Design

2008
openaire   +1 more source

Drug Design

2013
openaire   +1 more source

Drug Design

2004
Chung F. Wong, J. Andrew McCammon
openaire   +1 more source